Warfarin and Gemcitabine: Interaction Details
- Warfarin
- CoumadinJantoven
- Gemcitabine
- InfugemAvgemsiInlexzo
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Warfarin and Gemcitabine interaction:
Gemcitabine
- Infugem
- Avgemsi
- Inlexzo
What Happens When You Take Warfarin With Gemcitabine
What can happen when they are taken together (rated Major)
An increased risk of bleeding
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Two case reports involve patients on stable warfarin doses whose rose after gemcitabine was started. In the first, intravesicular gemcitabine was followed by a critically elevated INR, peaking at 8.6, along with hematomas.
Phytonadione was needed, and warfarin was stopped permanently.1 In the second, the patient's warfarin dose had to be lowered so that the INR stayed within the target range. When gemcitabine was discontinued, the warfarin dose had to be titrated back up to the earlier level.2
The Warfarin and Gemcitabine Interaction, Explained
Gemcitabine may make warfarin act stronger than usual, which can raise your risk of bleeding. Gemcitabine can temporarily irritate the liver. When that happens, the liver may break down warfarin more slowly and make fewer of the proteins that help blood clot. In two reported cases, people on steady warfarin doses saw their blood-thinning test () climb after starting gemcitabine. One had a very high INR and bleeding under the skin.
Your care team can manage this. They may check your INR more often, and your warfarin dose may need to be adjusted and individualized. Keep taking both as prescribed, and call your pharmacist or doctor right away if you notice unusual bruising, nosebleeds, or blood in your urine or stool.
Warfarin + gemcitabine: increased bleeding risk (supratherapeutic ). Proposed mechanism is reversible gemcitabine-associated , reducing warfarin and synthesis of clotting factors. Warfarin is a drug, so small changes in exposure matter. Onset is rapid; evidence is probable (two case reports).
- Case 1: INR peaked at 8.6 with hematomas (intravesicular gemcitabine); required phytonadione, warfarin permanently discontinued.
- Case 2: warfarin dose reductions needed to maintain target INR; dose returned to prior level after gemcitabine was stopped.
- Management: monitor INR closely at gemcitabine initiation and during therapy, individualize warfarin dosing, watch for bleeding, and re-titrate upward after gemcitabine discontinuation. Consider liver function monitoring.
See the 2 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Warfarin and Gemcitabine Interact
The likely mechanism
Reversible , reducing warfarin and decreasing synthesis of clotting factors
How to Manage the Warfarin and Gemcitabine Interaction
Your care team can usually manage this by watching your blood tests closely and tailoring your warfarin dose.
- Closer checks: your team may monitor you more closely when gemcitabine is started, and again when it is stopped.
- Dose changes: your warfarin dose may need to be adjusted and individualized by your care team. In one report the dose had to be lowered during treatment and then raised again afterward.
- What you should do: keep taking both medicines as prescribed, and do not change your warfarin on your own. Tell your pharmacist or prescriber right away about unusual bruising, bleeding, or blood in your urine or stool.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Warfarin or Gemcitabine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
2 reports from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine
A 90-year-old man had been taking warfarin 4 mg/day for 2 months for DVT, with a stable (2 to 3), when intravesicular gemcitabine 2 g was started for bladder cancer. He developed a critically elevated INR that peaked at 8.6 and resulted in hematomas.
The INR was within the after the second gemcitabine cycle but had risen to 7.4 by the end of the 4th cycle. A CT scan of the abdomen and pelvis showed a left psoas hematoma and a small left pectineus hematoma.
Warfarin was permanently discontinued and the patient was given phytonadione 5 mg orally, after which the INR fell to 1.8, and he was discharged on enoxaparin. On the Horn Drug Interaction Probability Scale, the interaction was rated probable, with a score of 6.1
-
Report 2 · Study title
Identification of a gemcitabine-warfarin interaction
A 63-year-old man who was stabilized on warfarin 57.5 mg/week ( 1.94) for atrial fibrillation was diagnosed with stage IV non-small cell lung cancer. Gemcitabine 2380 mg weekly for 3 weeks, followed by a 2-week rest period, was begun.
After the first gemcitabine dose, the INR rose to 3.52. Warfarin was reduced to 52.5 mg/week, and the INR fell to 2.08 and 2.13 during the 2-week gemcitabine rest period.
In the second gemcitabine cycle, the INR climbed to 3.58 even though warfarin had been reduced to 50 mg/week. Warfarin was lowered further to 48.5 mg/week, which achieved a therapeutic INR of 2.2.
Gemcitabine was stopped after the second cycle, and the INR values that followed were subtherapeutic. Warfarin had to be titrated upward again to the baseline dose of 57.5 mg/week. The patient had no emesis or weight loss from gemcitabine therapy, and no antiemetics were administered.2
Warfarin and Gemcitabine: Common Questions
How serious is the Warfarin and Gemcitabine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Warfarin and Gemcitabine interaction managed?
Your care team can usually manage this by watching your blood tests closely and tailoring your warfarin dose. Closer checks: your team may monitor you more closely when gemcitabine is started, and again when it is stopped. Dose changes: your warfarin dose may need to be adjusted and individualized by your care team. In one report the dose had to be lowered during treatment and then raised agai… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
Ask About the Warfarin and Gemcitabine Interaction
Ask in your own words about taking Warfarin and Gemcitabine together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (2)
- Kurtzhalts K, Gee ME, Feuz L, et al: Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine. Am J Health Syst Pharm 2016; 73(19):1508-1511. DOI
- Kinikar SA & Kolesar JM: Identification of a gemcitabine-warfarin interaction. Pharmacotherapy 1999; 19:1331-1333. PubMed
Other Serious Interactions of Warfarin and Gemcitabine
Also serious with Warfarin
- Defibrotide InjectionContraindicated
- Mifepristone (Korlym)Contraindicated
- Mifepristone (Mifeprex)Contraindicated
- TamoxifenContraindicated
Also serious with Gemcitabine
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Warfarin
- Vitamin KMajor
- GrapefruitMajor
- AlfalfaMajor
- St. John's WortMajor
- GlucosamineMajor
- CannabisMajor
- Activated CharcoalMajor
- GojiMajor
- + 360 more
With Gemcitabine
- WineMajor
- BeerMajor
- Siberian CockleburMajor
- Vitamin AModerate
- TurmericModerate
- Green TeaModerate
- AshwagandhaModerate
- Cassia CinnamonModerate
- + 31 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven. This interaction.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs. This interaction.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.